Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients

Coccina, Francesca; Pierdomenico, Anna M.; Ianni, Umberto; Rosa, Matteo de; Luca, Andrea De; Pirro, Davide; Pizzicannella, Jacopo; Trubiani, Oriana; Cipollone, Francesco; Renda, Giulia; Pierdomenico, Sante D.

doi:10.1111/jch.14112

Cited by 6 publications

(21 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The pooled population consisted of 7224 patients who experienced 444 cases of AF. The majority of the studies, 14 , 15 , 17 , 18 except one, 16 included subjects aged ≥40 years. Mean follow‐up ranged from 6 to 16 years.…”

Section: Resultsmentioning

confidence: 99%

“…The first literature search identified 302 studies. Of these, 7 were eligible after revision of titles and abstracts 12‐18 . Two studies 12,13 were excluded because they did not report separate data for clinic and/or daytime, nighttime and 24‐h BP.…”

Section: Methodsmentioning

confidence: 99%

“…Of these, 7 were eligible after revision of titles and abstracts. 12 , 13 , 14 , 15 , 16 , 17 , 18 Two studies 12 , 13 were excluded because they did not report separate data for clinic and/or daytime, nighttime and 24‐h BP. Thus, 5 studies 14 , 15 , 16 , 17 , 18 were included.…”

Section: Methodsmentioning

confidence: 99%

“… 12 , 13 , 14 , 15 , 16 , 17 , 18 Two studies 12 , 13 were excluded because they did not report separate data for clinic and/or daytime, nighttime and 24‐h BP. Thus, 5 studies 14 , 15 , 16 , 17 , 18 were included. Selection of publications is summarized in Figure 1 .…”

Section: Methodsmentioning

confidence: 99%

“…[5][6][7][8][9][10][11] In such a context, some studies have also evaluated whether ambulatory BP is superior to clinic BP in predicting new-onset AF. [12][13][14][15][16][17][18] It has been reported that daytime, [16][17][18] nighttime, [15][16][17][18] and 24-h BP [13][14][15][16][17][18] are independent predictors of new-onset AF and that these ambulatory BP measures tend to be superior to clinic BP [16][17][18] in predicting future AF. However, as there is still little information on this subject, 19 pooling all available evidence could allow for a more robust assessment of the association between AF and clinic and ambulatory BP.…”

mentioning

confidence: 99%

See 4 more Smart Citations

Association of clinic and ambulatory blood pressure with new‐onset atrial fibrillation: A meta‐analysis of observational studies

Coccina

Pierdomenico

Rosa

et al. 2021

J of Clinical Hypertension

Self Cite

View full text Add to dashboard Cite

Various studies have shown that hypertension, 1,2 through different mechanisms, 3 is an important risk factor for incident atrial fibrillation (AF) which in turn increases cardiovascular risk. 4 Clinic blood pressure (BP) recording is traditionally used for diagnosis and management of hypertension. However, it has been largely reported that ambulatory BP is superior to clinic BP in predicting cardiovascular outcome. [5][6][7][8][9][10][11] In such a context, some studies have also evaluated whether ambulatory BP is superior to clinic BP in predicting new-onset AF. [12][13][14][15][16][17][18] It has been reported that daytime, [16][17][18] nighttime, [15][16][17][18] and 24-h BP [13][14][15][16][17][18] are independent predictors of new-onset AF and that these ambulatory BP measures tend to be superior to clinic BP [16][17][18] in predicting future AF. However, as there is still little information on this subject, 19 pooling all available evidence could allow for a more robust assessment of the association between AF and clinic and ambulatory BP.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

See 3 more Smart Citations

Association of clinic and ambulatory blood pressure with new‐onset atrial fibrillation: A meta‐analysis of observational studies

Coccina

Pierdomenico

Rosa

et al. 2021

J of Clinical Hypertension

Self Cite

View full text Add to dashboard Cite

show abstract

ECG abnormality and predictor of new‐onset atrial fibrillation in hypertension and diabetes mellitus population: An observational analytic study from cardiovascular outpatient clinic at a National Cardiovascular Center in Indonesia

Kikuko,

Julario,

Puspitasari

et al. 2023

Journal of Arrhythmia

View full text Add to dashboard Cite

BackgroundPopulation‐based studies have also found that diabetes mellitus (DM) and hypertension (HT) are independent risk factors for atrial fibrillation (AF). However, less is known about new‐onset atrial fibrillation (NOAF) risk factors and its correlation with DM and HT. The aim of this study was to determine the prevalence and pattern of ECG abnormalities, and the predictor of NOAF in patients with HT and DM.MethodsThis cross‐sectional study was conducted at a tertiary hospital from May until December 2021. All medical record data from outpatients who had both diagnoses HT and DM were included in this study. Data from patients with unstable hemodynamics and lack of complete medical record data were excluded. Then, patient history, medical records, ECG, and laboratory information were reviewed.ResultsThere were 162 patients included in this study. Arrhythmia was found in 14.2% of the population, with new‐onset AF (NOAF) as the most common finding with 8.6% incidence, followed by PVC (3.1%) and PAC (2.5%). Bivariate analysis showed that valvular heart disease, random blood glucose, LVEF, and infection status were associated with a higher incidence of NOA. Model from multivariate logistic regression showed that valvular heart disease and random blood glucose level were independently correlated with NOAF (p = .009).ConclusionIt can be concluded that random blood glucose level at a certain point and valvular heart disease can be used as a risk predictor of NOAF in the hypertension population with concomitant DM.

show abstract

Epidemiology and modifiable risk factors for atrial fibrillation

et al. 2023

View full text Add to dashboard Cite

Review articledecades, supporting the view that the increasing global burden of AF is the consequence of a growing population living longer in the presence of chronic risk factors. Importantly, the total number of DALYs associated with AF has risen significantly, from 3.8 million in 1990 to 8.4 million in 2019 (ref. 1 ). The contribution to AF-associated DALYs of modifiable risk factors, such as hypertension, alcohol consumption, obesity and smoking, has also risen considerably over the same period 1 (Fig. 1). Lifetime riskIn Europe and the USA, an estimated 25% of individuals aged >55 years will develop AF over their lifespan 5,6 . However, several important factors modify this lifetime risk, including race and ethnicity, sex, and burden of clinical comorbidities [7][8][9][10][11] . In the USA, the risk of AF seems to be higher among white people than in Black or Hispanic individuals 7-9 . Similar patterns have been observed in the UK, where the incidence of AF among white individuals exceeds that for Black or Asian individuals 10 . In a database of >10 million participants in China, the lifetime risk of AF was approximately 20% 11 . Although no direct comparisons between racial or ethnic groups were made in this study, these data support a lower lifetime risk of AF in Asian than in Western populations.An interaction between race and sex also seems to be present. In the Atherosclerosis Risk in Communities (ARIC) study 12 , the lifetime risk of AF was higher in white men than in white women (36% versus 30%, respectively). Although the lifetime risk of AF in Black participants was lower than for white individuals, it did not differ significantly between men and women (21% and 22%, respectively) 12 . An elevated risk of AF among men has been shown elsewhere in cohorts of individuals of European ancestry 6 . In contemporary analyses from the FHS, the overall lifetime risk of AF at index age 55 years was 37% and was higher in men than in women, regardless of the underlying clinical risk factor profile 13 . By contrast, data from four European cohorts pooled as part of the BiomarCaRE consortium indicated that, although the onset of AF in women tended to be approximately 10 years later than in men, the lifetime risk was similar (~30%) 14 . Geographical disparitiesThe GBD 2019 study 1 revealed the highest age-standardized DALYs associated with AF in Australasia (168 per 100,000), North America (160 per 100,000 persons) and Europe (132 per 100,000). The lowest rates were observed for some countries in the Asia Pacific region (99 per 100,000), South America (91 per 100,000), sub-Saharan Africa (84 per 100,000) and the Middle East (82 per 100,000). However, the low DALYs reported in these regions could be due to a lack of available data and lower rates of AF diagnosis. In addition, differences in risk factor prevalence and genetics may contribute to the geographical disparities in AF incidence. Clinical risk factor scoresCombining clinical risk factors into a composite score provides strong predictive capability for the i...

show abstract

Ambulatory blood pressure and risk of new‐onset atrial fibrillation in treated hypertensive patients

Cited by 6 publications

References 38 publications

Association of clinic and ambulatory blood pressure with new‐onset atrial fibrillation: A meta‐analysis of observational studies

Association of clinic and ambulatory blood pressure with new‐onset atrial fibrillation: A meta‐analysis of observational studies

ECG abnormality and predictor of new‐onset atrial fibrillation in hypertension and diabetes mellitus population: An observational analytic study from cardiovascular outpatient clinic at a National Cardiovascular Center in Indonesia

Epidemiology and modifiable risk factors for atrial fibrillation

Contact Info

Product

Resources

About